Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shari Pilon-Thomas

Showing results (61-70 of 101) with videos related to

Pageof 11
Sort By:
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 28, 2025
Targeted degradation of the HPV oncoprotein E6 reduces tumor burden in cervical cancerTracess B Smalley, Angelo A Nicolaci, Kim C Tran, et al.
International Immunopharmacology|February 26, 2021
Expansion of tumor-infiltrating lymphocytes (TIL) from penile cancer patientsAhmet Murat Aydin, MacLean Hall, Brittany L Bunch, et al.
Nature Medicine|November 17, 2005
Inhibiting Stat3 signaling in the hematopoietic system elicits multicomponent antitumor immunityMarcin Kortylewski, Maciej Kujawski, Tianhong Wang, et al.
Neuro-Oncology|March 11, 2016
M011L-deficient oncolytic myxoma virus induces apoptosis in brain tumor-initiating cells and enhances survival in a novel immunocompetent mouse model of glioblastomaAlexandra Pisklakova, Brienne McKenzie, Franz Zemp, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|September 22, 2012
Efficacy of adoptive cell transfer of tumor-infiltrating lymphocytes after lymphopenia induction for metastatic melanomaShari Pilon-Thomas, Lisa Kuhn, Sabine Ellwanger, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 16, 2020
Diversity Outbred Mice Reveal the Quantitative Trait Locus and Regulatory Cells of HER2 ImmunityWei-Zen Wei, Heather M Gibson, Jennifer B Jacob, et al.
Cancer Research|January 1, 2016
Neutralization of Tumor Acidity Improves Antitumor Responses to ImmunotherapyShari Pilon-Thomas, Krithika N Kodumudi, Asmaa E El-Kenawi, et al.
International Journal of Radiation Oncology, Biology, Physics|June 29, 2025
Local Single-Dose Radiation Improves Adoptive Cell Therapy With Tumor-Infiltrating LymphocytesNina Obertopp, Rebecca A Bekker, G Daniel Grass, et al.
Frontiers in Immunology|October 30, 2023
Targeting myeloid-derived suppressor cells with gemcitabine to enhance efficacy of adoptive cell therapy in bladder cancerSarah Bazargan, Brittany Bunch, Awino Maureiq E Ojwang', et al.
Cancer Communications (London, England)|June 28, 2023
Safety and immunogenicity of a third dose of mRNA-1273 vaccine among cancer patientsAnna Giuliano, Barbara Kuter, Shari Pilon-Thomas, et al.
Pageof 11

Showing results (61-70 of 101) with videos related to

Sort By:
Pageof 11
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 28, 2025
Targeted degradation of the HPV oncoprotein E6 reduces tumor burden in cervical cancerTracess B Smalley, Angelo A Nicolaci, Kim C Tran, et al.
International Immunopharmacology|February 26, 2021
Expansion of tumor-infiltrating lymphocytes (TIL) from penile cancer patientsAhmet Murat Aydin, MacLean Hall, Brittany L Bunch, et al.
Nature Medicine|November 17, 2005
Inhibiting Stat3 signaling in the hematopoietic system elicits multicomponent antitumor immunityMarcin Kortylewski, Maciej Kujawski, Tianhong Wang, et al.
Neuro-Oncology|March 11, 2016
M011L-deficient oncolytic myxoma virus induces apoptosis in brain tumor-initiating cells and enhances survival in a novel immunocompetent mouse model of glioblastomaAlexandra Pisklakova, Brienne McKenzie, Franz Zemp, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|September 22, 2012
Efficacy of adoptive cell transfer of tumor-infiltrating lymphocytes after lymphopenia induction for metastatic melanomaShari Pilon-Thomas, Lisa Kuhn, Sabine Ellwanger, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 16, 2020
Diversity Outbred Mice Reveal the Quantitative Trait Locus and Regulatory Cells of HER2 ImmunityWei-Zen Wei, Heather M Gibson, Jennifer B Jacob, et al.
Cancer Research|January 1, 2016
Neutralization of Tumor Acidity Improves Antitumor Responses to ImmunotherapyShari Pilon-Thomas, Krithika N Kodumudi, Asmaa E El-Kenawi, et al.
International Journal of Radiation Oncology, Biology, Physics|June 29, 2025
Local Single-Dose Radiation Improves Adoptive Cell Therapy With Tumor-Infiltrating LymphocytesNina Obertopp, Rebecca A Bekker, G Daniel Grass, et al.
Frontiers in Immunology|October 30, 2023
Targeting myeloid-derived suppressor cells with gemcitabine to enhance efficacy of adoptive cell therapy in bladder cancerSarah Bazargan, Brittany Bunch, Awino Maureiq E Ojwang', et al.
Cancer Communications (London, England)|June 28, 2023
Safety and immunogenicity of a third dose of mRNA-1273 vaccine among cancer patientsAnna Giuliano, Barbara Kuter, Shari Pilon-Thomas, et al.
Pageof 11